Merck News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

09.06.14	Merck To Buy Idenix Pharma For About $3.85 Bln - Quick Facts (RTTNews)
06.06.14	Merck To Present 13 Studies And Analyses, Incl. Data For DPP-4 Inhibitor Januvia (RTTNews)
02.06.14	Merck Presents Data Evaluating Pembrolizumab As Initial Therapy At ASCO 2014 (RTTNews)
02.06.14	Merck: Pembrolizumab As Monotherapy Shows Estimated OS Rate Of 69% At One Year (RTTNews)
02.06.14	Novartis Names Merck Executive Strigini As Oncology Business Head (RTTNews)
30.05.14	Dako And Merck To Collaborate On Companion Diagnostic Test On Tumor PD-L1 Levels (RTTNews)
20.05.14	Merck Animal Health Says FDA Oks Bravecto Chewable Tablets For Dogs (RTTNews)
20.05.14	Merck : FDA Approves Bravecto Chewable Tablet For Dogs To Kill Fleas And Ticks (RTTNews)
16.05.14	Chimerix Regains Worldwide Rights To CMX157 From Merck - Quick Facts (RTTNews)
12.05.14	Merck Announces FDA Approval For ZONTIVITY - Quick Facts (RTTNews)
06.05.14	Merck To Sell Consumer Care Unit To Bayer For $14.2 Bln; Signs Collaboration (RTTNews)
06.05.14	Merck To Sell Consumer Care Unit To Bayer For $14.2 Bln - Quick Facts (RTTNews)
02.05.14	Endocyte Shares Plunge After Ovarian Cancer Drug Trial Halted - Update (RTTNews)
02.05.14	Endocyte & Merck Asked To Stop Phase 3 PROCEED Trial; Endocyte's Q1 Loss Widens (RTTNews)
29.04.14	Merck Q1 Profit Tops View Despite Revenue Drop (RTTNews)
29.04.14	Merck Q1 Profit Beats Consensus; Backs FY14 Targets - Quick Facts (RTTNews)
29.04.14	Reckitt Benckiser Confirms Talks To Acquire Merck's Consumer Health Business (RTTNews)
28.04.14	Agenus Signs Collaboration, License Agreement With Merck (RTTNews)
28.04.14	Merck Reportedly In Final Talks To Sell Consumer Unit For About $14 Bln (RTTNews)
28.04.14	Merck In Final Talks To Sell Consumer Healthcare Unit For About $14 Bln: Reports (RTTNews)
18.04.14	FDA Approves Ragwitek For Short Ragweed Pollen Allergies (RTTNews)
15.04.14	FDA Approve Merck's Grastek Tablet For Sublingual Use (RTTNews)
11.04.14	Merck Reports Interim Results From Ongoing C-WORTHy Trial - Quick Facts (RTTNews)
10.04.14	Xencor Receives Milestone Payment From Merck - Quick Facts (RTTNews)
10.04.14	Merck Reports Addl. Data From Ongoing C-WORTHy Trial - Quick Facts (RTTNews)
27.03.14	Baxter Plans To Split Into Two Companies - Quick Facts (RTTNews)
27.03.14	Merck Appoints Robert Davis To Succeed Peter Kellogg As CFO - Quick Facts (RTTNews)
24.03.14	Merck To Start Phase 3 Clinical Development Program In Q2 2014 - Quick Facts (RTTNews)
21.03.14	Merck And Endocyte Announce CHMP Positive Opinions For Vynfinit - Quick Facts (RTTNews)
06.03.14	Bio-Path To Uplist Shares, TKMR Gets A Shot In The Arm, Two To Go For NAVB (RTTNews)
05.03.14	Merck Announces New Data From HIV/HCV Co-infected Patients In C-WORTHY Study (RTTNews)
28.02.14	Merck Gets Positive CHMP Opinion For Tablet Formulation Of Noxafil - Quick Facts (RTTNews)
20.02.14	Merck's Biologics License Application For V503 Accepted For Review By FDA (RTTNews)
10.02.14	Merck, Samsung Bioepis To Develop & Commercialize Insulin Glargine Candidate (RTTNews)
05.02.14	Merck Q4 Profit Down 14%, But Matches View; Sees 2014 Earnings In-line (RTTNews)
05.02.14	Merck Q4 Adj. Profit Meets View, But Revenues Miss; Sees FY14 Adj.EPS In Line (RTTNews)
05.02.14	Merck, Amgen,Incyte And Pfizer To Collaborate On Anti-Cancer Combination Studies (RTTNews)
05.02.14	Amgen, Merck Collaborate To Evaluate Combination Treatment For Advanced Melanoma (RTTNews)
05.02.14	Earnings Watch For February 5 (HUM, MRK, TWX, DIS, P, TWTR) (RTTNews)
05.02.14	Novartis Said To Draw Interest From Possible Bidders For Vaccines Unit:Bloomberg (RTTNews)
04.02.14	DXCM Gets FDA Nod, MRK Breathes Easy, Neovasc Takes Heart, VRX Opens Wallet (RTTNews)
03.02.14	Merck Gets Regulatory Nod To Launch Grastek Sublingual Tablets In Canada (RTTNews)
03.02.14	Merck Reports Approval & Launch Of GRASTEK Sublingual Tablets In Canada (RTTNews)
03.02.14	Ablynx Enters Second Research Collaboration And Licensing Agreement With Merck (RTTNews)
29.01.14	FDA Panel Gives Thumbs Up To MRK's Allergy Pill, TXMD On A High, NYMX On Watch (RTTNews)
13.01.14	Alnylam Pharma To Buy Merck's Wholly Owned Subsidiary Sirna Therapeutics (RTTNews)
09.01.14	Dako To Collaborate With Merck To Develop Diagnostic Tests For Cancer Treatment (RTTNews)
08.01.14	Merck Obtains FDA Approval For Isentress For Pediatric Oral Suspension (RTTNews)
24.12.13	Actavis Confirms Generic NuvaRing Patent Lawsuit - Quick Facts (RTTNews)
20.12.13	Merck Launches New Company, HMR Weight Management Services - Quick Facts (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

09:28		Handel in Europa: STOXX 50 zum Start des Donnerstagshandels in Seitwärtsbewegung
09:28		Schwacher Wochentag in Zürich: SMI fällt zum Start
09:28		Pluszeichen in London: FTSE 100 zum Start des Donnerstagshandels in Grün
09:28		Schwache Performance in Zürich: SPI zum Start mit Abgaben
11.12.24		Dow Jones-Handel aktuell: Dow Jones verbucht letztendlich Verluste
11.12.24		Schwache Performance in New York: Dow Jones gibt nachmittags nach

09:28

Handel in Europa: STOXX 50 zum Start des Donnerstagshandels in Seitwärtsbewegung

09:28

Schwacher Wochentag in Zürich: SMI fällt zum Start

09:28

Pluszeichen in London: FTSE 100 zum Start des Donnerstagshandels in Grün

09:28

Schwache Performance in Zürich: SPI zum Start mit Abgaben

11.12.24

Dow Jones-Handel aktuell: Dow Jones verbucht letztendlich Verluste

11.12.24

Schwache Performance in New York: Dow Jones gibt nachmittags nach

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Lonza Grp	557.20	6.66 %	K V
CieFinRichemont	135.25	1.20 %	K V
UBS Group	28.59	1.02 %	K V
Alcon	76.70	0.81 %	K V
Holcim	89.90	0.76 %	K V
Logitech Intl	75.30	0.08 %	K V
Givaudan	4’042.00	0.05 %	K V
Roche Hldg G	255.00	-0.35 %	K V
Swiss Life Hldg	688.40	-0.49 %	K V
Kuehne+Nagel Int	205.30	-2.66 %	K V

Nachrichten zu Merck Co.

Aktien Top/Flop

Merck Peer Group Nachrichten

Meistgelesene Nachrichten